Clinical Trials
Gene Therapy Trial Now Recruiting Parkinson Patients
A Phase 2 study is testing AAV2-GDNF — a gene therapy delivered directly into the brain — to see if it can slow or improve motor symptoms in people with moderate Parkinson's (ages 45–75, diagnosed 4–10 years ago). This is a randomized, double-blind trial with sham surgery as the control group. Patients must have levodopa responsiveness but cannot have had prior brain surgery. Locations include UCSF in San Francisco and Loma Linda University in California, running through 2028 and aiming to enroll 127 participants. *
clinicaltrials.ucsf.eduGiant Phase 3 Trial Testing Antibody Drug in Early Parkinson's
A large Phase 3 study is enrolling 900 participants to test an IV antibody called prasinezumab in people with early-stage Parkinson's (ages 50–85). The drug targets alpha-synuclein — the protein that clumps in Parkinson's brains — aiming to slow disease progression. Participants must be on levodopa monotherapy with no motor complications. Running at UCSF (San Francisco) and Renown Health (Reno, NV) through June 2031. *
clinicaltrials.ucsf.eduKetamine Study Targets Depression in Veterans With Parkinson's
A randomized, placebo-controlled study at UCSF is testing whether a single IV dose of ketamine can rapidly improve depression in Veterans with Parkinson's disease. Depression is one of the most disabling non-motor symptoms of PD, and existing treatments often don't work well. The study also examines ketamine's effects on brain plasticity and inflammation — potentially hitting two underlying causes at once. Open to Veterans ages 40–80. *
clinicaltrials.ucsf.edu
Breakthrough Treatments
Adaptive Brain Stimulator Now FDA-Approved
The FDA approved a new adaptive deep brain stimulation device in February 2025. Unlike older DBS that fires constantly, this one watches your brain activity in real time and adjusts its electrical pulses only when needed — catching stiffness and tremors before they start. It's a major step up from the continuous-stimulation DBS that's been used since 1999 and is now available nationwide through Medtronic devices at major movement disorder centers. *
ucsf.eduFirst Disease-Slowing Drug Enters Final Testing
Roche is moving its drug prasinezumab into Phase III trials — the final stage before FDA review. It's the first treatment designed to actually slow Parkinson's by targeting alpha-synuclein, the protein that builds up in patients' brains. Phase II data showed positive signs of slowing motor decline, and over 750 patients are being tracked in ongoing follow-up studies. *
roche.comNew Once-Daily Pill Shows Strong Phase 3 Results, FDA Decision Pending
The drug tavapadon posted strong Phase 3 results across early and advanced Parkinson's patients, showing sustained improvement in motor symptoms with a favorable safety record. The FDA was reviewing it as of early 2026 — it's a once-daily pill that works differently than existing dopamine therapies, potentially offering smoother symptom control with fewer side effects like sleepiness and impulsivity. *
Lifestyle Interventions
Consistent Exercise Over 12 Weeks Drives Biggest Gains
A 2025 review of lifestyle research found that exercise programs lasting more than 12 weeks significantly improve motor function, thinking skills, and quality of life in Parkinson's patients. Both aerobic exercise (like walking or cycling) and strength training showed benefits. Patients should aim for long-term, consistent exercise routines rather than short bursts. Sleep problems affect nearly 88% of Parkinson's patients and make both movement and non-movement symptoms worse — treating sleep helps overall outcomes. *
pubmed.ncbi.nlm.nih.govPoor Sleep May Speed Up Parkinson's Progression
A 2025 animal study found that sleep deprivation accelerates Parkinson's progression through changes in gut bacteria, brain inflammation, and oxidative stress. When mice were sleep-deprived, their Parkinson's symptoms got worse faster — and probiotic supplements reversed some of these effects. This suggests that good sleep habits and gut health may help slow the disease. Patients with sleep problems should talk to their doctor, as treating sleep disorders may protect brain health. *
pubmed.ncbi.nlm.nih.govMediterranean Diet Linked to Slower Parkinson's Progression
A 2025 lifestyle review found that Mediterranean or MIND diets are linked to slower Parkinson's progression, while poor dietary habits worsen outcomes. Researchers studied centenarians in "Blue Zones" — regions where people live past 100 with low Parkinson's rates — and found that diet, exercise, and social connections play a major protective role. A simple daily framework from this research: EAT, MOVE, SLEEP, PROTECT, REPEAT. *
pubmed.ncbi.nlm.nih.gov
Emerging Research
Stem Cell Neuron Transplants Pass Safety Tests
Two major clinical trials transplanted lab-grown dopamine-releasing brain cells into Parkinson's patients. Results show the procedures are safe — a huge milestone. Effectiveness still needs proof, but this brings cell replacement therapy closer to reality as a potential cure-like approach. *
nature.comParkinson's Targets a Whole-Body Action Network, Not Just Motor Areas
Precision brain imaging reveals Parkinson's affects a specific circuit called the somato-cognitive action network — brain regions that coordinate whole-body movement. This over-connected network is normalized by existing drugs and brain stimulation. New DBS devices can now target this network more precisely, potentially improving outcomes for movement and non-motor symptoms alike. *
nature.comGut Bacteria Transplants Eased Early Parkinson's Motor Symptoms
A fecal transplant — transferring healthy donor gut bacteria into Parkinson's patients — safely improved both movement symptoms and constipation in early-stage patients not yet on medication. This adds to evidence that the gut-brain connection plays a role in Parkinson's progression and opens a potential new therapeutic pathway. *
parkinsonsnewstoday.com
This report is for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.